All Pharmaceutical industry articles
View all stories with this category.
-
BusinessMerck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
Webinar
Robots in the lab – learn how automation can streamline your workflow
The future of lab automation is promising. Join us on 27 February to find out answers to the most important questions, and to contribute your knowledge and experience to the discussion.
-
Business
Second Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects
-
Opinion
Setting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
Business
UK antibiotics supply chain stretched by surge in Strep A infections
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
-
Business
Pharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking
-
Business
Judge dismisses ranitidine lawsuits over lack of evidence
Drug degrades to produce nitrosamines, but the judge ruled the link between this and plaintiffs’ cancers could not be proven
-
Business
Theranos leaders to be imprisoned for blood testing fraud
Sunny Balwani and Elizabeth Holmes will both serve more than 10 years
-
Business
US government intervenes to avert rail strike
Congress enforces a contract deal to prevent a national rail shutdown that would effectively halt chemicals production
-
Sponsored
Time waits for no scientist: Five ways to enhance lab productivity and stay ahead of the competition in 2023
Manage your resources effectively to maximise your lab’s core activity: science
-
Opinion
Embracing oddities
When new chemistry looks like alchemy or witchcraft, it’s worth taking notice
-
Sponsored
Thermal analysis in the development of long-acting injectable systems
Evaluating new polymers for slow-release drug delivery could deliver better treatment for patients
-
Opinion
What to expect when your customer’s quality auditor visits
Checking a chemical plant is meeting standards
-
Webinar
Analytical impurity standards – minimise project risk & avoid common pitfalls
Learn how to save time and money by understanding what’s at stake when working with analytical impurity standards.
-
Business
Europe gears up for streamlined patent system
Delayed Unified Patent Court set to begin operating in April
-
Business
UK firms face critical lab space shortage
Growing chemistry companies hit a wall when it comes to expanding their labs
-
Sponsored
Inspiring a new era of patient-centric medicines
Christian Jones discusses new formulations for drug delivery that put people first
-
Sponsored
New frontiers in synthesis for a more sustainable future
AstraZeneca’s collaborations with academia are essential to harnessing the latest technology in the pursuit of new and sustainable medicines
-
Business
Contaminated cough syrup linked to 66 child deaths in The Gambia
Medicines made by Indian generics firm Maiden Pharmaceuticals have been blamed for acute kidney injuries
-
Feature
Tiny delivery systems for cancer drugs
Encapsulating anticancer agents in nanoparticles can make them gentler on the rest of the body. Clare Sansom reports
